Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study

Shuhei Fukunaga(Kurume University), Takuji Torimura(Omuta hospital), Dan Nakano(Kurume University), Tsutomu Nagata(Kurume University), Hidemichi Kawata(Kurume University Hospital), Ryuichi Nouno(Kumamoto Chuo Hospital), Keiichi Mitsuyama(Kurume University), Mohammed Eslam(The University of Sydney), Hidefumi Kuroki(Kurume University Hospital), Takumi Kawaguchi(Kurume University), Akihiro Ouchi(Kurume University), Koutaro Kawaguchi, Hirohiko ABE(Kumamoto Chuo Hospital), Jacob George(University of Dundee)
International Journal of Molecular Sciences
May 22, 2021
10.3390/ijms22115462
Cited by 58

Related Papers

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
|Hepatology International|2020|841
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536